MEDP MEDPACE HLDGS INC

Ownership history in Grantham, Mayo, Van Otterloo & Co. LLC  ·  13 quarters on record

AI Ownership Summary

Grantham, Mayo, Van Otterloo & Co. LLC reported MEDPACE HLDGS INC (MEDP) in 13 quarterly 13F filings from 2023 Q4 through 2025 Q3. Peak portfolio weight reached 0.07% in 2023 Q4. The latest visible filing shows MEDP at 0.05% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this MEDP ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Grantham, Mayo, Van Otterloo & Co. LLC's position in MEDPACE HLDGS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

MEDP was reported at 0.05% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.07% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Grantham, Mayo, Van Otterloo & Co. LLC held MEDP — position size vs. price
% of Fund (quarterly)    MEDP price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 ADDED 34,097 +319 +0.9% 0.05% $17.5M 2025-11-13 $591.32
2025 Q2 ADDED 33,778 +11,768 +53.5% 0.03% $10.6M 2025-08-13 $468.00
2025 Q1 ADDED 22,010 +4,818 +28.0% 0.02% $6.7M 2025-05-14 $291.73
2024 Q4 REDUCED 17,192 -21,045 -55.0% 0.02% $5.7M 2025-02-13 $342.41
2024 Q2 ADDED 38,237 +3,432 +9.9% 0.05% $15.7M 2024-08-13 $384.18
2024 Q1 REDUCED 34,805 -16,760 -32.5% 0.05% $14.1M 2024-05-14 $398.52
2023 Q4 REDUCED 51,565 -2,444 -4.5% 0.07% $15.8M 2024-02-13 $364.10
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Grantham, Mayo, Van Otterloo & Co. LLC and MEDP

These are the practical questions this page is built to answer before you even open the full history table.

How long has Grantham, Mayo, Van Otterloo & Co. LLC reported owning MEDP?

Grantham, Mayo, Van Otterloo & Co. LLC reported MEDP across 7 quarterly 13F filings, from 2023 Q4 through 2025 Q3.

What was the largest reported MEDP position in Grantham, Mayo, Van Otterloo & Co. LLC's portfolio?

The largest reported portfolio weight for MEDP was 0.07% in 2023 Q4.

What is the latest reported MEDP position on this page?

The most recent filing on this page is 2025 Q3, when Grantham, Mayo, Van Otterloo & Co. LLC reported 34,097 shares, equal to 0.05% of portfolio, with an estimated market value of $17.5M.

What does the chart on this MEDP ownership page compare?

The chart compares Grantham, Mayo, Van Otterloo & Co. LLC's quarterly MEDP portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Grantham, Mayo, Van Otterloo & Co. LLC Holdings